QPRT, P2Y11, and Breast Cancer Invasion
2026-08-21
Liu et al. show that quinolinate phosphoribosyltransferase (QPRT), a NAD+ biosynthetic enzyme, is associated with invasive breast cancer and promotes migration and invasion through a purinergic signaling network linked to myosin light-chain phosphorylation. Genetic and pharmacological perturbation supports a QPRT–P2Y11–Rho/ROCK–PLC/MLCK axis, while also highlighting the need for receptor-specific validation.
IL-1β–NF-κB Control of ACE2 in Macrophage Infection
2026-08-20
This preprint proposes that IL-1β-driven NF-κB activity dynamically increases ACE2 expression in macrophages, creating a route to SARS-CoV-2 infection that is not apparent from baseline receptor expression alone. A native-promoter humanized ACE2 mouse model showed pulmonary infection with a more resilient phenotype than the K18-hACE2 model, offering a framework for separating viral susceptibility from fulminant disease.
Annexin V-Cy5/DAPI Apoptosis Kit: Assay Logic
2026-08-20
The Annexin V-Cy5/DAPI Apoptosis Kit supports rapid apoptosis and necrosis analysis while preserving the distinction between membrane events and mitochondrial mechanism. This evidence-driven guide explains how to interpret K2255 data in Ph+ ALL and drug-response experiments.
Hypoxia, Choroid Plexus, and Cognitive Impairment
2026-08-19
This study identifies choroid plexus blood–cerebrospinal fluid barrier disruption as a central event linking simulated high-altitude hypoxia to cognitive dysfunction in mice. Its proposed cascade connects aberrant AMPK signaling and oxidative stress with M1 macrophage polarization, offering a barrier- and immune-centered framework for studying hypoxic CNS injury.
Vina-Ginsenoside R18: Dual-Target Dengue Inhibitor
2026-08-19
A 2025 study identifies vina-ginsenoside R18 as a dual-target dengue antiviral that interferes with both envelope-protein-mediated adsorption and RNA replication. Its value lies in linking two mechanistically distinct stages of infection, although additional pharmacological, serotype-specific, and clinical studies are needed.
Norepinephrine Formulations in Critical Care Research
2026-08-18
The SCCM–ESICM position paper identifies a consequential but often overlooked source of variability: norepinephrine may be labeled and dosed as a conjugated salt or as norepinephrine base. Its central contribution is a global reporting framework intended to improve dose interpretation, patient safety, clinical decision-making, and comparability across critical care studies.
3X FLAG Peptide: Assay Design for Rigor
2026-08-17
The 3X (DYKDDDDK) Peptide is more than a high-signal FLAG reagent: it is a practical tool for separating antibody recognition, protein recovery, and mechanistic claims. This guide connects its chemistry to assay controls, metal sensitivity, structural biology, and lessons from nimbolide chemoproteomics.
FNPs for Stable Lung-Directed mRNA Delivery
2026-08-17
The reference study introduces five-element nanoparticles (FNPs) that combine poly(β-amino esters) with DOTAP to improve lung-directed mRNA delivery and formulation stability. Its structure–activity analysis and lyophilization results suggest a practical route toward storage-stable extrahepatic delivery systems, while also defining important limits for translating reporter-mRNA performance into therapeutic conclusions.
Acridine Orange hydrochloride: Practical Guide
2026-08-16
Acridine Orange hydrochloride provides a practical fluorescent readout for nucleic-acid content, with green and red emission patterns that can support DNA/RNA differential staining, cell cycle analysis, apoptosis detection, and flow cytofluorometric workflows. It should be used as a nucleic-acid staining reagent with freshly prepared solutions, not as a stand-alone proof of apoptosis or as a long-term stored solution.
From CBS Biology to Translational Mouse Genotyping
2026-08-15
A mechanistic study of host-derived CBS in Staphylococcus aureus udder infection illustrates why dependable mouse genotyping is a strategic foundation for translational research. This article connects barrier biology, experimental validation, and scalable tissue-to-PCR workflows.
SB 202190: A p38–Cell-Death Decision Framework
2026-08-15
SB 202190 is a selective p38 MAP kinase inhibitor for dissecting how stress signaling intersects with apoptosis and necroptosis. This guide translates RIPK1 phosphoregulation findings into practical assay design for inflammation research, cancer therapeutics research, and neurobiology models.
AIBP–LRP2–HDL Axis in Collateral Circulation
2026-08-14
The reference study identifies an AIBP–LRP2–HDL–miR-223 pathway that restrains the expansion of CXCR4-positive, stemlike capillary endothelial cells during collateral vessel formation. Its combination of patient profiling, ischemic mouse models, genetic perturbation, and mechanistic testing suggests that restoring CXCR4 activity could improve revascularization, although clinical translation remains to be established.
α2-AR Agonists in Osteosarcoma Recurrence
2026-08-14
The reference study investigates local delivery of the α2-adrenergic receptor agonist UK14,304 after osteosarcoma resection, showing reduced recurrence in immunocompetent mice without substantial direct effects on tumor-cell viability, migration, or invasion in vitro. Proteomic and bioinformatic analyses connect the response to CD8+ T-cell activity, T-cell receptor signaling, ITGAL-centered regulation, and possible liquid-liquid phase separation.
ALDH2 Activation Delays Heart Failure in Mice
2026-08-13
A 2025 Experimental Cell Research study identifies ALDH2 as a regulator of cardiomyocyte proliferative capacity, not only as a mitochondrial enzyme involved in aldehyde metabolism. Pharmacological ALDH2 activation extended the early postnatal proliferative window and delayed pressure overload-induced heart failure in adult mice, suggesting a regenerative strategy that requires further validation.
CUDC-907 Protocol and QC Guidance
2026-08-13
CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, histone acetylation, cell-cycle progression, and apoptosis. This guidance uses the product dossier rather than directly matched paper evidence and is intended for research workflows only, not diagnostic, clinical, or therapeutic use.
507 records 11/34 page Previous Next First page 上5页 1112131415 下5页 Last page